Biegger David

Director Biegger David bought 1,000 shares at blended avg $49.14; now holds 8,488 shares. Stock down 47.2% from 52-week high; cluster pattern with 3 other insiders buying in past 14 days.

Director David Biegger executed 3 separate purchases totaling 1,000 shares for $49,142.30 on 2026-05-18, increasing his holdings by 13.4% to 8,488 shares. The timing coincides with significant price pressure: the stock has declined 47.2% from its 52-week high of $89.80 and is down 31.8% over the past 30 days and 35.1% over 90 days. His prior buy at FRPT on 2025-02-24 posted negative returns at both 30-day (-20.6%) and 90-day (-21.4%) intervals, establishing a pattern of unfavorable entry timing at this ticker. However, the simultaneous buying activity by 3 other insiders within the past 14 days creates a cluster pattern that may indicate internal assessment of valuation opportunity, though the company's fundamentals remain solid with $297.6M revenue, $48.5M net income, and 13.0% annual revenue growth. The convergence of steep price declines, repeated insider buying, and maintained financial performance warrants attention to whether this represents a bottom-fishing pattern or whether further deterioration is anticipated.

Director David Biegger buys 1,500 FRPT shares at $107.49; 5 other insiders bought within 14 days as stock down 33.4% in 30 days.

David Biegger, a director at Freshpet, purchased 1,500 shares for $161,235.00 on 2025-02-24, increasing his holdings by 50.6% from 2,967 to 4,467 shares. This transaction occurs amid a significant cluster buy pattern: 5 other insiders have purchased shares within the past 14 days, coinciding with a steep 30-day decline of -33.4% and a 90-day decline of -30.2% from the 52-week high of $162.59. The company demonstrates solid fundamentals with annual revenue growth of +27.2%, trailing-twelve-month revenue of $253,367,000.00, and net income of $11,895,000.00, though the stock trades at an elevated 41.75 P/E ratio. The coordinated purchasing activity across multiple insiders during a sharp drawdown, combined with the company's revenue growth trajectory, warrants examination of whether the price decline has created a valuation inflection point in the market's assessment of the business.